[
1. Morris S, Cerceo E. Trends, Epidemiology, and Management of Multi-Drug Resistant Gram-Negative Bacterial Infections in the Hospitalized Setting. Antibiotics (Basel). 2020 Apr;9(4):196. DOI: 10.3390/antibiotics904019610.3390/antibiotics9040196723572932326058
]Search in Google Scholar
[
2. Horcajada JP, Montero M, Oliver A, Sorlí L, Luque S, Gómez-Zorrilla S, et al. Epidemiology and Treatment of Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa Infections. Clin Micro-biol Rev. 2019 Aug;32(4):e00031-19. DOI: 10.1128/CMR.00031-1910.1128/CMR.00031-19673049631462403
]Search in Google Scholar
[
3. Ibrahim S, Al-Saryi N, Al-Kadmy IMS, Aziz SN. Multidrug-resistant Acinetobacter baumannii as an emerging concern in hospitals. Mol Biol Rep. 2021 Oct;48(10):6987-98. DOI: 10.1007/s11033-021-06690-610.1007/s11033-021-06690-6840353434460060
]Search in Google Scholar
[
4. Nordmann P, Poirel L. Epidemiology and Diagnostics of Carbapenem Resistance in Gram-negative Bacteria. Clin Infect Dis. 2019 Nov;69(Suppl7):S521-8 DOI: 10.1093/cid/ciz82410.1093/cid/ciz824685375831724045
]Search in Google Scholar
[
5. Tacconelli E, Carrara E, Savoldi A, Harbarth S, Mendelson M, Monnet DL, et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis. 2018 Mar;18(3):318-327.
]Search in Google Scholar
[
6. Gra-a-Miraglia L, Evans BA, López-Jácome LE, Hernández-Durán M, Colín-Castro CA, Volkow-Fernández P, et al. Origin of OXA-23 Variant OXA-239 from a Recently Emerged Lineage of Acinetobacter baumannii International Clone V. mSphere. 2020 Jan;5(1):e00801-19. DOI: 10.1128/mSphere.00801-1910.1128/mSphere.00801-19695219931915222
]Search in Google Scholar
[
7. Karakonstantis S, Kritsotakis EI, Gikas A. Treatment options for K. pneumoniae, P. aeruginosa and A. baumannii co-resistant to carbapenems, aminoglycosides, polymyxins and tigecycline: an approach based on the mechanisms of resistance to carbapenems. Infection. 2020 Dec;48(6):835-51. DOI: 10.1007/s15010-020-01520-610.1007/s15010-020-01520-6746176332875545
]Search in Google Scholar
[
8. Hamidian M, Nigro SJ. Emergence, molecular mechanisms and global spread of carbapenem-resistant Acinetobacter baumannii. Microb Genom. 2019 Oct;5(10):e000306. DOI: 10.1099/mgen.0.00030610.1099/mgen.0.000306686186531599224
]Search in Google Scholar
[
9. Bansal G, Allen-McFarlane R, Eribo B. Antibiotic Susceptibility, Clonality, and Molecular Characterization of Carbapenem-Resistant Clinical Isolates of Acinetobacter baumannii from Washington DC. Int J Microbiol. 2020 Jun;2020:2120159. DOI: 10.1155/2020/212015910.1155/2020/2120159736820532695174
]Search in Google Scholar
[
10. Lukovic B, Gajic I, Dimkic I, Kekic D, Zornic S, Pozder T, et al. The first nationwide multicenter study of Acinetobacter baumannii recovered in Serbia: emergence of OXA-72, OXA-23 and NDM-1-producing isolates. Antimicrob Resist Infect Control. 2020 Jul;9(1):101. DOI: 10.1186/s13756-020-00769-810.1186/s13756-020-00769-8733812532631451
]Search in Google Scholar
[
11. Tamma PD, Simner PJ. Phenotypic Detection of Carbapenemase-Producing Organisms from Clinical Isolates. J Clin Microbiol. 2018 Oct;56(11):e01140-18. DOI: 10.1128/JCM.01140-1810.1128/JCM.01140-18620467330158194
]Search in Google Scholar
[
12. Huang XZ, Cash DM, Chahine MA, Nikolich MP, Craft DW. Development and validation of a multiplex TaqMan real-time PCR for rapid detection of genes encoding four types of class D carbapenemase in Acinetobacter baumannii. J Med Microbiol. 2012 Nov;61(Pt 11):1532-7. DOI: 10.1099/jmm.0.045823-010.1099/jmm.0.045823-022878252
]Search in Google Scholar
[
13. Khosravi Y, Loke MF, Chua EG, Tay ST, Vadivelu J. Phenotypic detection of metallo-β-lactamase in imipenem-resistant Pseudomonas aeruginosa. Scientific World Journal. 2012 Jun;2012:654939. DOI: 10.1100/2012/65493910.1100/2012/654939338559922792048
]Search in Google Scholar
[
14. Amjad A, Mirza IA, Abbasi S, Farwa U, Malik N, Zia F. Modified Hodge test: A simple and effective test for detection of carbapenemase production. Iran J Microbiol. 2011 Dec;3(4):189-93.
]Search in Google Scholar
[
15. van der Zwaluw K, de Haan A, Pluister GN, Boots-ma HJ, de Neeling AJ, Schouls LM. The carbapenem inactivation method (CIM), a simple and low-cost alternative for the Carba NP test to assess phenotypic carbapenemase activity in gram-negative rods. PLoS One. 2015 Mar;10(3):e0123690. DOI: 10.1371/journal. pone.0123690
]Search in Google Scholar
[
16. Goudarzi H, Mirsamadi ES, Ghalavand Z, Hakemi Vala M, Mirjalali H, Hashemi A. Rapid detection and molecular survey of blaVIM, blaIMP and blaNDM genes among clinical isolates of Acinetobacter baumannii using new multiplex real-time PCR and melting curve analysis. BMC Microbiol. 2019 Jun;19(1):122. DOI: 10.1186/s12866-019-1510-y10.1186/s12866-019-1510-y655883031182026
]Search in Google Scholar
[
17. Boiculese V, Dimitriu G, Moscalu M. Biostatistica -Analiza statistică a datelor biologice. Editor PIM, Iaşi, Romania, 2007.
]Search in Google Scholar
[
18. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012 Mar;18(3):268-81. DOI: 10.1111/j.1469-0691.2011.03570.x10.1111/j.1469-0691.2011.03570.x21793988
]Search in Google Scholar
[
19. Stoeva T, Higgins PG, Bojkova K, Seifert H. Clonal spread of carbapenem-resistant OXA-23-positive Acinetobacter baumannii in a Bulgarian university hospital. Clin Microbiol Infect. 2008 Jul;14(7):723-7. DOI: 10.1111/j.1469-0691.2008.02018.x10.1111/j.1469-0691.2008.02018.x18558947
]Search in Google Scholar
[
20. Mugnier PD, Poirel L, Naas T, Nordmann P. Worldwide dissemination of the blaOXA-23 carbapenemase gene of Acinetobacter baumannii. Emerg Infect Dis. 2010 Jan;16(1):35-40. DOI: 10.3201/eid1601.09085210.3201/eid1601.090852287436420031040
]Search in Google Scholar
[
21. Rodríguez CH, Nastro M, Famiglietti A. Carbapenemases in Acinetobacter baumannii. Review of their dissemination in Latin America. Rev Argent Micro-biol. 2018 Jul-Sept;50(3):327-33. DOI: 10.1016/j. ram.2017.10.006
]Search in Google Scholar
[
22. Timofte D, Panzaru CV, Maciuca IE, Dan M, Mare AD, Man A, et al. Active surveillance scheme in three Romanian hospitals reveals a high prevalence and variety of carbapenamase-producing Gram-negative bacteria: a pilot study, December 2014 to May 2015. Euro Surveill. 2016;21:pii=30262. DOI: 10.2807/1560-7917. ES.2016.21.25.30262
]Search in Google Scholar
[
23. Mereuţă AI, Bădescu AC, Dorneanu OS, Iancu LS, Tuchiluş CG. Spread of VIM-2 metallo-β-lactamase in Pseudomonas aeruginosa and Acinetobacter baumannii clinical isolates from Iaşi, România. Rev Rom Med Lab. 2013;21:423-30. DOI: 10.2478/rrlm-2013-003510.2478/rrlm-2013-0035
]Search in Google Scholar
[
24. Bonnin RA, Poirel L, Licker M, Nordmann P. Genetic diversity of carbapenem-hydrolysing β-lactamases in Acinetobacter baumannii from Romanian hospitals. Clin Microbiol Infect. 2011 Oct;17(10):1524-8. DOI: 10.1111/j.1469-0691.2011.03622.x10.1111/j.1469-0691.2011.03622.x21883667
]Search in Google Scholar
[
25. Radu-Popescu MA, Dumitriu S, Enache-Soare S, Bancescu G, Udristoiu A, Cojocaru M, et al. Phenotypic and genotypic characterization of antibiotic resistance patterns in Acinetobacter baumannii strains isolated in a Romanian hospital. Farmacia. 2010;58(3):362-367.
]Search in Google Scholar
[
26. Gheorghe I, Cristea VC, Marutescu L, Popa M, Murariu C, Trusca BS, et al. Resistance and Virulence Features in Carbapenem-resistant Acinetobacter baumannii Community Acquired and Nosocomial Isolates in Romania. Rev Chim. 2019 Nov;70(10):3502-7. DOI: 10.37358/RC.19.10.758410.37358/RC.19.10.7584
]Search in Google Scholar
[
27. Gheorghe I, Barbu IC, Surleac M, Sârbu I, Popa LI, Paraschiv S, et al. Subtypes, resistance and virulence platforms in extended-drug resistant Acinetobacter baumannii Romanian isolates. Sci Rep. 2021 Jun;11(1):13288. DOI: 10.1038/s41598-021-92590-510.1038/s41598-021-92590-5822588234168184
]Search in Google Scholar
[
28. Moulana Z, Babazadeh A, Eslamdost Z, Shokri M, Ebrahimpour S. Phenotypic and genotypic detection of metallo-beta-lactamases in Carbapenem resistant Acinetobacter baumannii. Caspian J Intern Med. 2020;11(2):171-6.
]Search in Google Scholar
[
29. Sun K, Xu X, Yan J, Zhang L. Evaluation of Six Phenotypic Methods for the Detection of Carbapenemases in Gram-Negative Bacteria With Characterized Resistance Mechanisms. Ann Lab Med. 2017 Jul;37(4):305-12. DOI: 10.3343/alm.2017.37.4.30510.3343/alm.2017.37.4.305540902728445009
]Search in Google Scholar
[
30. Abouelfetouh A, Torky AS, Aboulmagd E. Phenotypic and genotypic characterization of carbapenem-resistant Acinetobacter baumannii isolates from Egypt. Anti-microb Resist Infect Control. 2019 Nov;8:185. DOI: 10.1186/s13756-019-0611-610.1186/s13756-019-0611-6686875231832185
]Search in Google Scholar
[
31. El-Kazzaz W, Metwally L, Yahia R, Al-Harbi N, El-Taher A, Hetta HF. Antibiogram, Prevalence of OXA Carbapenemase Encoding Genes, and RAPD-Genotyping of Multidrug-Resistant Acinetobacter baumannii Incriminated in Hidden Community-Acquired Infections. Antibiotics (Basel). 2020 Sep;9(9):603. DOI: 10.3390/antibiotics909060310.3390/antibiotics9090603755896032942596
]Search in Google Scholar
[
32. Bonnin RA, Naas T, Poirel L, Nordmann P. Phenotypic, biochemical, and molecular techniques for detection of metallo-β-lactamase NDM in Acinetobacter baumannii. J Clin Microbiol. 2012 Apr;50(4):1419-21. DOI: 10.1128/JCM.06276-1110.1128/JCM.06276-11331853722259204
]Search in Google Scholar
[
33. Howard JC, Creighton J, Ikram R, Werno AM. Comparison of the performance of three variations of the Carbapenem Inactivation Method (CIM, modified CIM [mCIM] and in-house method (iCIM)) for the detection of carbapenemase-producing Enterobacterales and non-fermenters. J Glob Antimicrob Resist. 2020 Jun;21:78-82. DOI: 10.1016/j.jgar.2020.03.02110.1016/j.jgar.2020.03.02132278885
]Search in Google Scholar
[
34. Pierce VM, Simner PJ, Lonsway DR, Roe-Carpenter DE, Johnson JK, Brasso WB, et al. Modified Carbapenem Inactivation Method for Phenotypic Detection of Carbapenemase Production among Enterobacteriaceae. J Clin Microbiol. 2017 Aug;55(8):2321-33. DOI: 10.1128/JCM.00193-1710.1128/JCM.00193-17552741028381609
]Search in Google Scholar
[
35. Aktaş E, Malkoçoğlu G, Otlu B, Çopur Çiçek A, Külah C, Cömert F, et al. Evaluation of the carbapenem inactivation method for detection of carbapenemase-producing gram-negative bacteria in comparison with the Rapidec Carba NP. Microb. Drug Resist. 2017 Jun;23(4):457-61. DOI: 10.1089/mdr.2016.009210.1089/mdr.2016.009227575912
]Search in Google Scholar
[
36. Uddin F, McHugh TD, Roulston K, Platt G, Khan TA, Sohail M. Detection of carbapenemases, AmpC and ESBL genes in Acinetobacter isolates from ICUs by DNA microarray. J Microbiol Methods. 2018 Dec;155:19-23. DOI: 10.1016/j.mimet.2018.11.00410.1016/j.mimet.2018.11.00430423363
]Search in Google Scholar
[
37. Riccobono E, Bogaerts P, Antonelli A, Evrard S, Giani T, Rossolini GM, et al. Evaluation of the OXA-23 K-SeT® immunochromatographic assay for the rapid detection of OXA-23-like carbapenemase-producing Acinetobacter spp. J Antimicrob Chemother. 2019 May;74(5):1455-7. DOI: 10.1093/jac/dkz00110.1093/jac/dkz00130689921
]Search in Google Scholar
[
38. Bedenić B, Ladavac R, Vranić-Ladavac M, Barišić N, Karčić N, Sreter KB, et al. False Positive Phenotypic Detection of Metallo-Beta-Lactamases in Acinetobacter baumannii. Acta Clin Croat. 2019 Mar;58(1):113-8. DOI: 10.20471/acc.2019.58.01.1510.20471/acc.2019.58.01.15662921231363333
]Search in Google Scholar
[
39. Segal H, Elisha BG. Use of Etest MBL strips for the detection of carbapenemases in Acinetobacter baumannii. J Antimicrob Chemother. 2005 Jul;56(3):598. DOI: 10.1093/jac/dki26510.1093/jac/dki26516046465
]Search in Google Scholar
[
40. Aksoy MD, Çavuşlu Ş, Tuğrul HM. Investigation of Metallo Beta Lactamases and Oxacillinases in Carbapenem Resistant Acinetobacter baumannii Strains Isolated from Inpatients. Balkan Med J. 2015 Jan;32(1):79-83. DOI: 10.5152/balkanmedj.2015.1530210.5152/balkanmedj.2015.15302434214225759776
]Search in Google Scholar
